Inventor
Kelly L. DAMM-GANAMET
Inventor
US
Overview
Patents· 1 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07BGeneral methods of organic chemistry33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,516,038Inhibitors of antigen presentation by HLA-DR2026Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2026Patents assigned to JANSSEN PHARMACEUTICA NV (1)· patent assignee history
2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 1 | 2026 |